Product Description
This digital document is an article from Internal Medicine News, published by International Medical News Group on August 15, 2002. The length of the article is 429 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Once-daily alfuzosin: good result, few side effects in pro static hyperplasia. (Under FDA Review).(benign prostatic hyperplasia treatment)
Publication: Internal Medicine News (Magazine/Journal)
Date: August 15, 2002
Publisher: International Medical News Group
Volume: 35Issue: 16Page: 6(1)

Article Type: Product/Service Evaluation

Distributed by Thomson Gale ... Read more

Product Description
This digital document is an article from Internal Medicine News, published by International Medical News Group on January 1, 2005. The length of the article is 915 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Stinging nettle for benign prostatic hyperplasia.(ALTERNATIVE MEDICINE)
Author: Nancy Walsh
Publication: Internal Medicine News (Magazine/Journal)
Date: January 1, 2005
Publisher: International Medical News Group
Volume: 38Issue: 1Page: 28(1)

Distributed by Thomson Gale ... Read more

Product Description
This digital document is an article from Family Practice News, published by International Medical News Group on January 15, 2005. The length of the article is 916 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Stinging nettle for benign prostatic hyperplasia.(Alternative medicine: an evidence-based approach)
Author: Nancy Walsh
Publication: Family Practice News (Magazine/Journal)
Date: January 15, 2005
Publisher: International Medical News Group
Volume: 35Issue: 2Page: 67(1)

Distributed by Thomson Gale ... Read more

Product Description
This digital document is an article from Phytomedicine: International Journal of Phytotherapy & Phytopharmacology, published by Thomson Gale on August 1, 2007. The length of the article is 3166 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Dose-response effect of Red Maca (Lepidium meyenii) on benign prostatic hyperplasia induced by testosterone enanthate.
Author: M. Gasco
Publication: Phytomedicine: International Journal of Phytotherapy & Phytopharmacology (Magazine/Journal)
Date: August 1, 2007
Publisher: Thomson Gale
Volume: 14Issue: 7-8Page: 460(5)

Distributed by Thomson Gale ... Read more

Product Description
This digital document is an article from Family Practice News, published by International Medical News Group on September 15, 2000. The length of the article is 650 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Benign Prostatic Hyperplasia? Use Terazosin First.(Brief Article)
Author: Bruce Jancin
Publication: Family Practice News (Magazine/Journal)
Date: September 15, 2000
Publisher: International Medical News Group
Volume: 30Issue: 18Page: 13

Article Type: Brief Article

Distributed by Thomson Gale ... Read more

Product Description
In recent years, significant strides have been made in understanding benign prostatic hyperplasia (BPH) and finding nonsurgical alternatives for its treatment. This volume highlights the current knowledge of the disease process, including papers on the pathophysiology and aetiology of BPH. It also looks at important forms of treatment, in particular the efficacy of Finasteride, a new 5-alpha reductase inhibitor which acts selectively on the prostate and thereby leads to significantly fewer side-effects. ... Read more

Product Description
A textbook and CD-ROM package. It covers six main areas: basic science, epidemiology, evaluation, medical treatment, surgical/interventional options, and future directions. Other features include teaching notes, slide box facility, animated diagrams and interactive index. ... Read more

Product Description
This digital document is an article from Internal Medicine News, published by Thomson Gale on June 1, 2006. The length of the article is 900 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Alfuzosin slows clinical progression of BPH.(benign prostatic hyperplasia)(Drug overview)(Clinical report)
Author: Jane Salodof MacNeil
Publication: Internal Medicine News (Magazine/Journal)
Date: June 1, 2006
Publisher: Thomson Gale
Volume: 39Issue: 11Page: 38(2)

Article Type: Clinical report, Drug overview

Distributed by Thomson Gale ... Read more

Product Description
This digital document is an article from Family Practice News, published by International Medical News Group on August 15, 2002. The length of the article is 592 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Dutasteride improves BPH symptoms, cuts prostate volume and PSA. (Fast-Acting Agent).(benign prostatic hyperplasia)
Publication: Family Practice News (Magazine/Journal)
Date: August 15, 2002
Publisher: International Medical News Group
Volume: 32Issue: 16Page: 20(1)

Distributed by Thomson Gale ... Read more

Product Description

Product Description
This digital document is an article from Family Practice News, published by International Medical News Group on December 1, 2001. The length of the article is 954 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Saw palmetto for benign prostatic hyperplasia. (Alternative Medicine).(Brief Article)
Author: Nancy Walsh
Publication: Family Practice News (Magazine/Journal)
Date: December 1, 2001
Publisher: International Medical News Group
Volume: 31Issue: 23Page: 8(1)

Article Type: Brief Article

Distributed by Thomson Gale ... Read more

Product Description
This digital document is an article from Internal Medicine News, published by International Medical News Group on October 1, 2003. The length of the article is 841 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: BPH diagnosis and management. (benign prostatic hyperplasia).(The Effective Physician)
Author: William E. Golden
Publication: Internal Medicine News (Magazine/Journal)
Date: October 1, 2003
Publisher: International Medical News Group
Volume: 36Issue: 19Page: 27(1)

Distributed by Thomson Gale ... Read more

Product Description
Abstract:It has been long appreciated that a healthy lifestyle plays a critical role in cardiovascular health. It is now apparent that the same is true in the development of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). Since 1995, 14 studies have been identified that investigate the clinical relationship between exercise and BPH/LUTS. No randomized controlled trials have been performed, but useful prospective cohort data originating from recent publications on the medical treatment of BPH and prevention of prostate cancer are available. Most of the literature supports a clinically significant, independent, and strong inverse relationship between exercise and the development of BPH/LUTS. Several mechanisms for this relationship have been proposed, including decreased sympathetic tone, avoidance of metabolic syndrome, and reduced oxidative damage to the prostate. ... Read more

Product Description
To Help men learn about Benign Prostatic Hyperplasia(BPH).Provides answers to frequently asked questions, such as, roleof the prostate, symptoms, when to see a doctor, when treatment isneeded, what treatments are available, can medication help and whensurgery is necessary. ... Read more

Product Description

The spectrum of available treatment options for benign prostatic hyperplasia (BPH) is matched by the spectrum of disease severity, and with up to 90% of men in their 80s suffering from BPH to some extent, it is imperative that patients are offered the full range of options to manage the disease.

Pharmacologic therapies available for the treatment of lower urinary tract symptoms secondary to BPH include alpha-adrenoceptor antagonists, such as terazosin, doxazosin, alfuzosin and tamsulosin, and the 5-alpha-reductase inhibitors, finasteride and dutasteride. Other strategies, such as plant-derived medication or watchful waiting, are applied to varying extents.

Derived from the benchmark title on BPH - Textbook of Benign Prostatic Hyperplasia - this well written and highly illustrated guide covers all these therapies and presents physicians with all they need to know to successfully manage the disease.